Literature DB >> 81274

Transient muscular weakness in severe recessive myotonia congenita. Improvement of isometric muscle force by drugs relieving myotomic stiffness.

K Ricker, A Haass, G Hertel, H G Mertens.   

Abstract

The maximum force of voluntary muscle contraction was registered under isometric conditions in nine patients with recessive myotonia congenita. The recordings were made on the upper arm. Five patients with severe myotonia had a transient weakness after muscle rest. Electromyographic registrations with wire electrodes showed that the myotonic muscle fiber discharges disappeared during the transient weakness. Medication improving myotonic stiffness also improved the weakness. The cause of transient weakness seems to be similar to that of myotonic stiffness. It is known that an increasing depolarization of the myotonic muscle fiber membrane leads to the myotonic discharges and myotonic stiffness. In severe myotonia the progressing depolarization could cause a loss of excitability of the muscle fiber membrane and thereby a transient paresis of a more or less large number of muscle fibers.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 81274     DOI: 10.1007/BF00312881

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  13 in total

1.  On the repetitive discharge in myotonic muscle fibres.

Authors:  R H Adrian; S H Bryant
Journal:  J Physiol       Date:  1974-07       Impact factor: 5.182

2.  [Congenital myotonia, muscular weakness treated by exertion and muscular hypertrophy].

Authors:  M P Castaigne; D Laplane; P Augustin; G Dordain; C Penders
Journal:  Rev Neurol (Paris)       Date:  1973-07       Impact factor: 2.607

3.  Electromyographic studies in myotonia congenita.

Authors:  J F Kirby; G H Kraft
Journal:  Arch Phys Med Rehabil       Date:  1973-02       Impact factor: 3.966

4.  Muscular paralysis in myotonia congenita.

Authors:  K Ricker; H M Meinck
Journal:  Eur Neurol       Date:  1972       Impact factor: 1.710

5.  [Muscular weakness corrected by exercise accompanying a muscular hypertrophy with myotonia].

Authors:  O Sabouraud; M Bourel; M Chatel; J Le Bars
Journal:  Rev Neurol (Paris)       Date:  1965-06       Impact factor: 2.607

6.  The declining electrical response of muscle to repetitive nerve stimulation in myotonia.

Authors:  M J Aminoff; R B Layzer; S Satya-Murti; A I Faden
Journal:  Neurology       Date:  1977-09       Impact factor: 9.910

7.  [Familial case of myotonia with muscular hypertrophy, weakness corrected by effort and atrophy of type II fibers].

Authors:  B Pépin; M Haguenau; J Mikol
Journal:  Rev Neurol (Paris)       Date:  1975-04       Impact factor: 2.607

8.  Clinical and electrophysiological observations in patients with myotonic muscle disease and the therapeutic effect of N-propyl-ajmalin.

Authors:  K L Birnberger; R Rüdel; A Struppler
Journal:  J Neurol       Date:  1975-09-01       Impact factor: 4.849

9.  [Neurophysiological studies on the temporary paresis in myotonia congenita and dystrophia myotonica].

Authors:  K Ricker; H M Meinch; H Stumpf
Journal:  Z Neurol       Date:  1973-04-02

10.  Weakness in myotonic syndromes.

Authors:  C M Wiles; R H Edwards
Journal:  Lancet       Date:  1977-09-17       Impact factor: 79.321

View more
  7 in total

1.  Evidence for genetic homogeneity in autosomal recessive generalised myotonia (Becker).

Authors:  M C Koch; K Ricker; M Otto; F Wolf; B Zoll; C Lorenz; K Steinmeyer; T J Jentsch
Journal:  J Med Genet       Date:  1993-11       Impact factor: 6.318

Review 2.  Channelopathies of skeletal muscle excitability.

Authors:  Stephen C Cannon
Journal:  Compr Physiol       Date:  2015-04       Impact factor: 9.090

Review 3.  Clinical evaluation of membrane excitability in muscle channel disorders: potential applications in clinical trials.

Authors:  James C Cleland; Eric L Logigian
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

Review 4.  Do multiple ionic interactions contribute to skeletal muscle fatigue?

Authors:  S P Cairns; M I Lindinger
Journal:  J Physiol       Date:  2008-06-26       Impact factor: 5.182

Review 5.  The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment.

Authors:  E Matthews; D Fialho; S V Tan; S L Venance; S C Cannon; D Sternberg; B Fontaine; A A Amato; R J Barohn; R C Griggs; M G Hanna
Journal:  Brain       Date:  2009-11-16       Impact factor: 13.501

Review 6.  Drug treatment for myotonia.

Authors:  J Trip; G Drost; B G M van Engelen; C G Faber
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

7.  Health status in non-dystrophic myotonias: close relation with pain and fatigue.

Authors:  J Trip; J de Vries; G Drost; H B Ginjaar; B G M van Engelen; C G Faber
Journal:  J Neurol       Date:  2009-03-01       Impact factor: 4.849

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.